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FIGURE 4. Bar graph depicting remaining and dislodged fiducial markers
after electromagnetic navigation bronchoscopy (ENB). Coiled fiducial
markers (2 of 217) showed highly significant lower dislodgment rate com-
pared with linear fiducial markers compared with previous studies by
Anantham and colleagues10 and Harley and colleagues.11 P values calcu-
lated using Fisher’s exact test.
Schroeder et al Evolving Technology/Basic ScienceThe use of coil spring fiducial markers was 99% success-
ful for accurate and durable placement. From the published
studies, a fiducial loss rate of more than 10% has been com-
mon and results in a greater need of repeat placements and/or
a suboptimal CyberKnife tracking accuracy. The deployment
of coil spring fiducial markers using a common specimen
brush is easy to perform for any trained bronchoscopist.
The coil spring fiducial markers are more expensive (about
$104 vs $65) than the classic linear type. The lower dislodge-
ment rate should negate the need for repeat fiducial
placement10 and its attendant costs in materials, staff, and
periprocedural risk.E
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Dr Bryan Fitch Meyers (St. Louis, Mo). I see that there are ac-
tually several alternatives, and youmentioned some. You could use
percutaneous placement of these fiducials with a greater risk of
pneumothorax, but presumably that could be done with just a local
anesthetic. Your method has a pneumothorax risk as well, albeit
lower, but it would require more sedation or anesthetics, and peo-
ple would have to weigh the pros and cons of those different ap-
proaches. What was the sedation or anesthetic that you gave in
all or most of these patients, and could you just talk a little bit about
the setting of the procedure and the duration of the procedure?
Dr Schroeder. The maximum duration was up to 1 hour. We
got better with the learning curve. If it is just a straight fiducial
placement, we are down to a 20-minute procedure. It all depends
on whether you actually have an easy way to reach the tumor.
The patients are in moderate sedation in an out-patient setting.
We actually tap into the system of our pulmonology colleagues,
and fentanyl and midazolam is normally used.
I honestly think the lower rate of pneumothorax is worthwhile
to undergo a moderate sedation protocol. You see in some studies
every other patient has a pneumothorax with the treatment of a pig-
tail catheter and being in the hospital. I think that is an important
comorbidity.diovascular Surgery c Volume 140, Number 5 1141
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SDr Robert J. Cusimano (Toronto, Ontario, Canada). Just
a small question. I am a cardiac surgeon so I do not know about
these things. The coil markers, are they ferromagnetic? Can you
perform magnetic resonance imaging afterward?
Dr Schroeder.Yes, you can perform magnetic resonance imag-
ing. They stay in. They are platinum.
Dr Arjun Pennathur (Pittsburgh, Pa). Great presentation.
How many patients actually underwent biopsy that was proven?
It looked like on your last slide you said about 45%. So were other
55% still going to undergo transthoracic computed tomography
(CT)-guided biopsy? How did you perform biopsies on the rest
of the patients?1142 The Journal of Thoracic and Cardiovascular SurDr Schroeder. We are a secondary center, so we often have
people referred from the outside who had undergone bronchos-
copy or CT-guided biopsy beforehand.
Dr Pennarthur. How was your success rate for a peripheral
lesion with a navigational bronchoscopy to get a tissue
diagnosis?
Dr Schroeder. Our biopsy rate is about in the 50% range. I
know that in other hands with navigational bronchoscopy alone
it is in the 70% range. So, our rate was about 50%, unfortunately.
Dr Pennarthur. So, in those patients you would still perform
CT-guided biopsy?
Dr Schroeder. Or a repeat bronchoscopy is another possibility.gery c November 2010
